✦ LIBER ✦

The value of computerized tomography as a routine follow-up procedure for patients with Wilms' tumor

✍ Scribed by Wilimas, Judith A. ;Hammond, Elizabeth ;Douglass, Edwin C. ;Champion, John ;Parvey, Louis ;Coburn, Thomas

Publisher: John Wiley and Sons
Year: 1984
Tongue: English
Weight: 225 KB
Volume: 12
Category: Article
ISSN: 0098-1532
DOI: 10.1002/mpo.2950120316

No coin nor oath required. For personal study only.

✦ Synopsis

We performed routine computerized tomography (CT) of the chest and abdomen on patients treated for Wilms' tumor and reviewed the records of all patients who relapsed (10 patients) and 43 additional patients followed for at least 1 year. Routine chest radiographs and abdominal ultrasounds were compared with 210 CT examinations (107 chest and 103 abdomen). CT examinations were obtained at 6 months for stage I (13 patients) and at 3, 8, and 15 months for stages II, III, and IV (40 patients). Of the 10 patients who relapsed, only 2 were documented by CT scan in the absence of clinical symptomatology and presence of normal radiographs and ultrasound. Eight relapses were diagnosed by physical examination, chest radiograph, or ultrasound and confirmed by CT scan. Questionably abnormal CT scans were obtained in 7 patients, only 1 of whom eventually relapsed. Since only 2 of 210 routine CT examinations were the the only indicator of relapse, we conclude that the routine use of CT for follow-up in Wilms' tumor is not warranted.

📜 SIMILAR VOLUMES

The value of routine follow-up in patien

The value of routine follow-up in patients treated for carcinoma of the vulva

✍ Maaike H. M. Oonk; Joanne A. de Hullu; Harry Hollema; Marian J. E. Mourits; Elis 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB 👁 1 views

## BACKGROUND. Vulvar carcinoma patients traditionally are offered follow-up after their primary treatment because earlier diagnosis of recurrent disease is believed to improve chances for curative treatment. The objective of the current study was to determine the value of a strict routine follow-

Serum CA 125 is of clinical value in the

Serum CA 125 is of clinical value in the staging and follow-up of patients with non-Hodgkin's lymphoma : Correlation with tumor parameters and disease activity

✍ Ikram A. Burney; Tariq Siddiqui; Imran Siddiqui 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 30 KB 👁 3 views

W e read with interest the article published in Cancer earlier this year regarding the elevation of CA 125 in patients with non-Hodgkin's lymphoma and its normalization with clinical response. 1 Earlier a case report had also emerged about elevation of CA 125 in a patient within tuberculous peritoni

Long-term follow-up of autologous stem c

Long-term follow-up of autologous stem cell transplantation in patients with diffuse mantle cell lymphoma in first disease remission : The prognostic value of β2-microglobulin and the tumor score

✍ Issa F. Khouri; Rima M. Saliba; Grace-Julia Okoroji; Sandra A. Acholonu; Richard 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 2 views

BACKGROUND. The current study was conducted to analyze the long-term results of autologous stem cell transplantation (ASCT) in patients with diffuse mantle cell lymphoma (MCL) in first disease remission. METHODS. Thirty-three patients were treated. Thirty-one patients had Ann Arbor Stage III or Stag

Assessment of cytologic follow-up as the

Assessment of cytologic follow-up as the recommended management for patients with atypical squamous cells of undetermined significance or low grade squamous intraepithelial lesions

✍ Alanen, Ken W. ;Elit, Laurie M. ;Molinaro, Patricia A. ;McLachlin, Catherine M. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB 👁 2 views

## Background: The optimal management of low grade papanicolaou (pap) smear abnormalities remains controversial. this center's experience with recommending cytologic follow-up for women with atypical cells of undetermined significance (ascus) or low grade squamous intraepithelial lesions (lsil) was

The prognostic value of p53 and c-erb b-

The prognostic value of p53 and c-erb b-2 immunostaining is overrated for patients with lymph node negative breast carcinoma : A multivariate analysis of prognostic factors in 613 patients with a follow-up of 14–30 years

✍ Wenche Reed; Einar Hannisdal; Per Johannes Boehler; Stein Gundersen; Herman Host 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 2 views

## BACKGROUND. Approximately 30% of breast carcinoma patients with negative lymph nodes die of their disease. Biologic markers such p53 protein and c-erb B-2 have been related to tumor progression, but their prognostic value remains controversial. ## METHODS. Two large series of a total of 613 ly